SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

NVIDIA Corp. engages in the design and manufacture of computer graphics processors, chipsets, and related multimedia software. It operates through the following segments: Graphics Processing Unit (GPU) and Compute & Networking. The Graphics segment includes GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, Quadro and NVIDIA RTX GPUs for enterprise workstation graphics, virtual GPU, or vGPU, software for cloud-based visual and virtual computing, automotive platforms for infotainment systems, and Omniverse Enterprise software for building and operating metaverse and 3D internet applications. The Compute & Networking segment consists of Data Center accelerated computing platforms and end-to-end networking platforms including Quantum for InfiniBand and Spectrum for Ethernet, NVIDIA DRIVE automated-driving platform and automotive development agreements, Jetson robotics and other embedded platforms, NVIDIA AI Enterprise and other software, and DGX Cloud software and services. The company was founded by Jen Hsun Huang, Chris A. Malachowsky, and Curtis R. Priem in April 1993 and is headquartered in Santa Clara, CA.

NVIDIA Corp

NVIDIA is trending following strong earnings and an optimistic outlook for its AI-driven data center business, but the stock's muted reaction and subsequent dip have ignited community discussion debating whether the growth is already priced in, if market manipulation is at play, or if future revenue without China sales is a growing concern.

The Trade Desk, Inc. engages in the provision of a self-service and cloud-based ad-buying platform. It operates through the United States and International geographical segments. The firm offers omnichannel advertising, audience targeting, solutions for identity, application programming interface (API), custom, and programmatic, measurement and optimization. The company was founded by Jeffrey Terry Green and David Pickles in November 2009 and is headquartered in Ventura, CA.

Trade Desk Inc - Ordinary Shares - Class A

Trade Desk Inc

The Trade Desk is trending following its Q4 earnings beat, overshadowed by weaker Q1 revenue guidance that triggered a sharp stock decline. The community is deeply divided, with many believing the sell-off is an overreaction and buying the dip, while others are vocal about management concerns and expect further declines amidst competitive ad-tech pressures.

C3.ai, Inc. engages in the provision of enterprise artificial intelligence software for digital transformation. It delivers the C3 AI suite for developing, deploying, and operating large-scale AI, predictive analytics, and Internet of Things applications in addition to a portfolio of turn-key AI applications. It operates through the following geographical segments: North America, Europe, The Middle East, and Africa, Asia Pacific, and Rest of World. The company was founded by Thomas M. Siebel, Patricia A. House and Stephen Maurice Ward, Jr. on January 8, 2009 and is headquartered in Redwood City, CA.

C3.ai Inc - Ordinary Shares - Class A

C3.ai Inc

C3.ai is trending due to reports of potential merger talks with private firm Automation Anywhere, which could take the automation company public through the deal. This follows a disappointing earnings report and weak guidance, leading to community debate over whether it's a lifeline for the underperforming AI stock or further evidence of its struggles.

Salesforce, Inc. engages in the design and development of cloud-based enterprise software for customer relationship management. Its solutions include sales force automation, customer service and support, marketing automation, digital commerce, community management, collaboration, industry-specific solutions, and salesforce platform. The firm also provides guidance, support, training, and advisory services. The company was founded by Marc Russell Benioff and Parker Harris in 1999 and is headquartered in San Francisco, CA.

Salesforce Inc

Salesforce is a major talking point after reporting strong quarterly results and announcing a significant share repurchase program and dividend increase, yet the stock's market reaction has intensified community debate between those who see deep value and AI-driven growth against an overblown "software apocalypse" narrative, and others who remain concerned about AI's disruptive impact on traditional SaaS.

Enovix Corp. engages in the design and development of silicon-anode lithium-ion batteries. The firm's proprietary 3D cell architecture increases energy density and maintains a high cycle life. It is also developing its 3D cell technology and production process for the electric vehicle and energy storage markets to help enable utilization of renewable energy. The company was founded by Mr. Harrold Jones Rust, III, Ashok Lahiri, and Murali Ramasubramanian in November 2006 and is headquartered in Fremont, CA.

Enovix Corporation

Enovix Corp

Enovix is trending after its mixed earnings report, where an EPS beat and early demand for smart eyewear are overshadowed by persistent delays in smartphone qualification with its lead customer Honor, sparking a community debate over long-term execution and manufacturing yields.

IonQ, Inc. develops and manufactures quantum computers. The firm specializes in quantum computing and quantum information processing. The company was founded by Christopher Monroe and Jung Sang Kim in 2015 and is headquartered in College Park, MD.

IonQ Inc

IonQ is actively discussed after reporting strong financial results and optimistic guidance, further buoyed by a key defense contract and the SkyWater acquisition, which has prompted widespread bullish sentiment and expectations of a short squeeze despite counterarguments from critics citing alleged revenue misrepresentation and ongoing losses within the highly speculative quantum computing sector.

Larimar Therapeutics, Inc. Is a clinical-stage biopharmaceutical company, which engages in the research, development, and commercialization of novel therapeutics mitochondrial disorders and Friedreich's ataxia. The company was founded in 2005 and is headquartered in Bala Cynwyd, PA.

Larimar Therapeutics Inc

Larimar Therapeutics (LRMR) is surging after its nomlabofusp received FDA Breakthrough Therapy Designation for Friedreich's ataxia, which the community sees as a major step toward a potential blockbuster drug and has prompted analyst price target increases. However, a proposed public offering is generating mixed sentiment regarding near-term dilution despite the positive regulatory news.

Snowflake, Inc. engages in the provision of cloud data warehousing software. The firm offers Data Cloud, an ecosystem where Snowflake customers, partners, data providers, and data consumers can break down data silos and derive value from data. Its platform supports a range of use cases including data warehousing, data lakes, data engineering, data science, data application development, and data sharing. The cloud-native architecture consists of layers across storage, compute, and cloud services. The storage layer ingests structured and semi-structured data to create a unified data record. The compute layer provides dedicated resources to enable users to access common data sets for many use cases without latency. The cloud services layer optimizes each use case's performance requirements with no administration. The company was founded by Marcin Zukowski, Thierry Cruanes, and Benoit Dageville on July 23, 2012 and is headquartered in Bozeman, MT.

Snowflake Inc

Snowflake Inc. is trending after reporting strong Q4 performance but providing forward guidance that projects a slowdown in product revenue growth. This has sparked community discussions regarding the company's ability to monetize AI adoption and whether concerns about AI disruption in the broader software sector are justified for its data platform.

Zoom Communications, Inc. engages in the provision of a communications and collaboration platform. It operates through the following geographical segments: Americas, Asia Pacific, and Europe, Middle East, and Africa. The company was founded by Eric S. Yuan in 2011 and is headquartered in San Jose, CA.

Zoom Communications Inc. - Ordinary Shares - Class A

Zoom Video Communications, Inc.

Zoom is trending following its recent earnings report, which showcased robust cash flow and a substantial buyback authorization, further fueling discussions around its significant strategic investment in AI company Anthropic as a hidden asset. However, community sentiment reflects frustration that the stock's valuation has not yet fully appreciated these strong fundamentals and its AI-first vision, especially amid competitive pressures from platforms like Microsoft Teams.

Sezzle, Inc. engages in the operation of a digital payment platform that enables bank-to-bank transfer of money between consumers and businesses. The company was founded by Charlie G. Youakim, Killian Brackey and Paul V. Paradis on January 4, 2016 and is headquartered in Minneapolis, MN.

Sezzle Inc.

Sezzle is trending after reporting strong earnings that beat expectations and significantly raising its future guidance, fueling widespread community discussion about its perceived undervaluation compared to peers. With high short interest and a new $100 million share buyback program, many anticipate a substantial short squeeze and potential analyst upgrades.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

A Look Ahead: Rhythm Pharmaceuticals's Earnings Forecast

Hillsdale Investment Management Inc. Takes $4.30 Million Position in Rhythm Pharmaceuticals, Inc. $RYTM

Hillsdale Investment Management Inc. purchased a new position in Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM - Free Report) during the 3rd quarter, according to the company in its most recent 13F...

JPMorgan Chase & Co. Increases Stock Position in Rhythm Pharmaceuticals, Inc. $RYTM

JPMorgan Chase & Co. boosted its holdings in Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM - Free Report) by 51.6% in the third quarter, according to its most recent 13F filing with the Securities and...

Aberdeen Group plc Sells 40,917 Shares of Rhythm Pharmaceuticals, Inc. $RYTM

Aberdeen Group plc reduced its holdings in shares of Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM - Free Report) by 60.5% during the 3rd quarter, according to the company in its most recent 13F filing...

Royal Bank Of Canada Upgrades Rhythm Pharmaceuticals (NASDAQ:RYTM) to Moderate Buy

Royal Bank Of Canada raised shares of Rhythm Pharmaceuticals to a "moderate buy" rating in a research note on Wednesday...

Rhythm Pharmaceuticals (NASDAQ:RYTM) CFO Sells $444,025.10 in Stock

Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM - Get Free Report) CFO Hunter Smith sold 4,385 shares of the business's stock in a transaction dated Thursday, February 19th. The stock was sold at an...

Rhythm Pharmaceuticals (NASDAQ:RYTM) CFO Hunter Smith Sells 3,569 Shares

Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM - Get Free Report) CFO Hunter Smith sold 3,569 shares of the firm's stock in a transaction on Tuesday, February 17th. The stock was sold at an average price...

Rhythm Pharmaceuticals (NASDAQ:RYTM) CFO Hunter Smith Sells 4,385 Shares

Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM - Get Free Report) CFO Hunter Smith sold 4,385 shares of the stock in a transaction that occurred on Thursday, February 19th. The shares were sold at an...

Rhythm Pharmaceuticals Is Well-Positioned, Analyst Says Could Capture Big Share Of Rare Obesity Market

RBC launches Rhythm Pharma with Outperform, sees $2 billion Imcivree sales by 2030 after Phase 3 obesity data boost.read more...

Rhythm Pharmaceuticals, Inc. (RYTM) Expected to Beat Earnings Estimates: Should You Buy?

Rhythm Pharmaceuticals (RYTM) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Rhythm Pharmaceuticals, Inc. is a commercial-stage biopharmaceutical company, which engages in the development and commercialization of therapeutics for patients with rare diseases. The firm offers IMCIVREE (setmelanotide), a precision medicine designed to treat hyperphagia and severe obesity caused by rare melanocortin-4 receptor (MC4R) diseases. It is also involved in the clinical development program for setmelanotide in other rare MC4R pathway diseases, as well as a preclinical suite of investigational candidates for the treatment of congenital hyperinsulinism. The company was founded by Bart Henderson in November 2008 and is headquartered in Boston, MA.

RYTM
Rhythm Pharmaceuticals Inc.

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest RYTM News

RYTMRhythm Pharmaceuticals Inc.